Drug Type Biological products |
Synonyms SIM0692 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2/3 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bladder Cancer | Phase 3 | China | 13 Oct 2026 | |
| Breast Cancer | Phase 3 | China | 13 Oct 2026 | |
| Non-Small Cell Lung Cancer | Phase 3 | China | 13 Oct 2026 | |
| Small Cell Lung Cancer | Phase 3 | China | 13 Oct 2026 | |
| Thrombocytopenia | Phase 3 | China | 13 Oct 2026 | |
| Purpura, Thrombocytopenic, Idiopathic | Phase 1 | China | 05 Sep 2025 |





